Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | VNM47R2QSQ |
InChI Key | TZJALUIVHRYQQB-XLRXWWTNSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C33H40O15 |
Molecular Weight | 676.67 |
AlogP | 0.07 |
Hydrogen Bond Acceptor | 15.0 |
Hydrogen Bond Donor | 8.0 |
Number of Rotational Bond | 9.0 |
Polar Surface Area | 238.2 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 48.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Phosphodiesterase
Phosphodiesterase 5
Phosphodiesterase 5A
|
- | 5900 | - | - | - | |
Enzyme
Phosphodiesterase
Phosphodiesterase 6
Phosphodiesterase 6C
|
- | - | - | - | 45 | |
Epigenetic regulator
Eraser
Lysine demethylase
Lysine-specific demethylase
|
- | 26440 | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 127 |
Mesh Heading | Maximum Phase | Reference |
---|---|---|
Bipolar Disorder; Disease; Substance-Related Disorders | Phase 3 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 489-32-7 |
ChEBI | 78420 |
ChEMBL | CHEMBL553204 |
DrugBank | DB12052 |
FDA SRS | VNM47R2QSQ |
KEGG | C17555 |
PubChem | 5318997 |
SureChEMBL | SCHEMBL312615 |
ZINC | ZINC000003960893 |